PATIENTS FIRST. POWERED BY EVIDENCE.
LIVE

Serial Number

98288528

Owner

United BioSource LLC

Attorney

Lisa Casey Spaniel

Filing Date

Nov 28, 2023

Add to watchlist:

No watchlists yet
View on USPTO

PATIENTS FIRST. POWERED BY EVIDENCE. Trademark

Serial Number: 98288528

PATIENTS FIRST. POWERED BY EVIDENCE. is a trademark filed by United BioSource LLC on November 28, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 38 (Telecommunications), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

United BioSource LLC

Suite 200
Blue Bell, PA 19422

Entity Type: 16

Trademark Details

Filing Date

November 28, 2023

Registration Date

Not Registered

Goods & Services

consulting services in the cost management of health care, namely, cost management for the health care benefit plans of others, including health care benefit plans that have co-pay cards; medical cost management and administering medication reimbursement programs for others to improve health, affordability and patient experience; business consulting services featuring business analytics and information in the healthcare and pharmaceutical industries during drug development and commercialization, namely, business analytics and information in the fields of real world evidence, health economics, outcomes research, payer research and market access studies; strategic business data analysis and business advice regarding benefit cost management, pharmaceutical end-user behavior and healthcare use behavior; business consulting services in the fields of business risk minimization, business risk mitigation and business Risk Evaluation and Mitigation Strategies; business management of in-home care coordination services, business organization and management of a nationwide home health network, business organization and management of a nationwide injection network; business administration services, namely, customer relationship management services design and implementation of customer services solutions via various technology partnerships and custom configurations connecting vendors and services and hybrid operating platform designs and deployments; Business administration of co-pay programs for reimbursement of co-pays and access to medication discounts, benefit verification, claims administration and other support for reimbursement and access to benefits

Consulting services in the payment management of health care, namely, co-pay cards, therapeutic access, reimbursement, analysis of manufacturer program designs and medication discount benefits

consultation services in the field of research compliance, namely, regulatory compliance consultation services in the field of clinical trials involving human subjects; regulatory compliance consultation services in the field of informed consent protocols for clinical trial participants, Pregnancy registries, Pregnancy Root cause analysis, Risk Evaluation and Mitigation Strategy administration, Observational Research Real world Evidence, Real world Data, Knowledge Attitude and Behavior Surveys, Proprietary Risk Evaluation and Mitigation Strategy Platform, Expanded Patient Access Programs, Clinical Trial and Post Marketing Case Processing, Post Marketing Commitments, Post Marketing Requirements, Risk Minimization Plans, Risk Evaluation and Mitigation, Patient HUB, Benefit Investigation, Interventional Clinical Trials, Natural History Studies, Pragmatic Studies Design and Administration of Outcomes Based Agreements and value based agreements, Federated Registries, Integrated Registries, Decentralized Studies, and Patient Recruitment Strategies

downloadable computer software, computer software platforms, and mobile applications featuring digital assets and artificial intelligence for database management, analytics, modeling, monitoring, storage, validation, compliance, reimbursement management, scheduling, progress monitoring, benefits verification, reimbursements and case management in the field of Clinical Research, Safety Services, Risk Evaluation and Mitigation, Patient Support Services, Evidence Development and Data Analysis

printed materials, namely, brochures, manuals and handbooks featuring topics relating to health, medical and pharmaceutical education, training and testing in connection with patient assistance programs for the pharmaceutical and healthcare industries

healthcare services in the nature of remote and in-person patient support services, namely, nursing services, dose administration in the nature of patient engagement to ensure adherence to dosing protocols, and patient medical diagnostic monitoring services

educational, training and educational testing services, namely, conducting seminars, conferences and presentations featuring topics in the field of health, medical care and pharmaceutical industries; training and educational services, namely, conducting programs in the fields of health, medical care and pharmaceutical industries; training and educational services, namely, providing non-downloadable webcasts in the fields of health, medical care and pharmaceutical industries

webcasting services featuring topics in the field of health, medical care and pharmaceutical industries

medical and scientific research, namely, conducting clinical trials for others; basic and clinical research in the field of heath care and medicine; providing on-line non-downloadable software, computer software platforms, and applications featuring artificial intelligence and digital assets used to administer, advise, monitor, analyze or generate information related to Clinical Research, Safety Services, Risk Evaluation and Mitigation, Patient Support Services, Evidence Development and Data Analysis; non-downloadable software as a service (SAAS) technology platforms for database management, analytics, modeling, monitoring, storage, validation, compliance, payment management, scheduling, progress monitoring, benefits verification, reimbursements and cost management related to Clinical Research, Safety Services, Risk Evaluation and Mitigation, Patient Support Services, Evidence Development and Data Analysis; providing on-line non-downloadable software, platforms, and mobile applications featuring digital assets and artificial intelligence for database management, analytics, modeling, monitoring, storage, validation, compliance, payment management, scheduling, progress monitoring, benefits verification, reimbursements and cost management in the field of clinical research, safety services, risk evaluation and mitigation, patient support services, evidence development and data analysis; scientific research consulting services in the field of pharmacovigilance strategies to ensure regulatory compliance and patient safety in clinical trials and marketed pharmaceuticals involving human subjects; scientific research consulting services in the field of epidemiology; pharmaceutical product safety testing and consultancy efficacy services for the purposes of, namely, risk mitigation and pharmacovigilance services, prescription drug monitoring programs, analyzing clinical data in healthcare databases, clinical trials, health economics and outcomes research in the fields of healthcare and pharmaceuticals, organizing, managing, and tracking data during development of a clinical trial, creating and updating clinical guidelines in the fields of healthcare and pharmaceuticals

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 9, 2026 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 9, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 9, 2026 GNSL
SUSPENSION LETTER WRITTEN
Feb 9, 2026 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 7, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 7, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 7, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 7, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 7, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 7, 2025 GNRN
NON-FINAL ACTION E-MAILED
Apr 7, 2025 GNRT
NON-FINAL ACTION WRITTEN
Apr 7, 2025 CNRT
ASSIGNED TO EXAMINER
Feb 4, 2025 DOCK
ASSIGNED TO EXAMINER
Jan 10, 2025 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 29, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 29, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 29, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Sep 30, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Sep 30, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 29, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 29, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 29, 2024 CNRT
LETTER OF PROTEST EVIDENCE REVIEWED - ACTION TAKEN
Jun 29, 2024 LOPE
ASSIGNED TO EXAMINER
Jun 26, 2024 DOCK
LETTER OF PROTEST EVIDENCE FORWARDED
Mar 18, 2024 LOPT
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 22, 2024 NWOS
NEW APPLICATION ENTERED
Dec 1, 2023 NWAP